Evotec, a German pharmaceutical company, has published its latest sustainability report
5 December 2024, 3:00 PM GMT
Leveraging best-in-class climate risk disclosures to drive strategic business advantage
Join this Corporate Disclosures and FIS webinar to discover actionable insights that can turn climate risk data into a strategic advantage.
Most Read
- EFRAG approves two-part voluntary standard for SMEs
- IFRS report shows slow progress on TCFD uptake
- ASIC sets out regulatory regime for sustainability reporting
- IFRS offers update on ISSB capacity building initiatives
- EFRAG and CDP collaborate on climate disclosure mapping
- PwC highlights best practice in social reporting
- Deloitte: Sustainability reporting guide for Asia-Pacific companies
- Business associations call for simplification of CSDDD
- Leveraging best-in-class climate risk disclosures to drive strategic business advantage
- EFRAG releases working papers for non-EU ESRS
Latest Stories
-
CDP and GRI sign MoU at COP29
14 November 2024 -
IAASB publishes ISSA 5000
14 November 2024 -
GRI meets with Sustainability Standards Board of Japan
14 November 2024 -
Von der Leyen sets sights on omnibus regulation to consolidate EU transparency laws
14 November 2024 -
IFRS report shows slow progress on TCFD uptake
13 November 2024